Biliary and Pancreatic Tract

  • 3E0J Biliary and Pancreatic Tract
    • 3E0J3 Percutaneous
      • 3E0J30 Antineoplastic
        • 3E0J304 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach
        • 3E0J305 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach
        • 3E0J30M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J32 Anti-infective
        • 3E0J328 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach
        • 3E0J329 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J33 Anti-inflammatory
        • 3E0J33Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J36 Nutritional Substance
        • 3E0J36Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J37 Electrolytic and Water Balance Substance
        • 3E0J37Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3B Anesthetic Agent
        • 3E0J3BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3G Other Therapeutic Substance
        • 3E0J3GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3H Radioactive Substance
        • 3E0J3HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3K Other Diagnostic Substance
        • 3E0J3KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3N Analgesics, Hypnotics, Sedatives
        • 3E0J3NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3S Gas
        • 3E0J3SF Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3T Destructive Agent
        • 3E0J3TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach
      • 3E0J3U Pancreatic Islet Cells
        • 3E0J3U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
        • 3E0J3U1 Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
    • 3E0J4 Percutaneous Endoscopic
      • 3E0J4G Other Therapeutic Substance
        • 3E0J4GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach
    • 3E0J7 Via Natural or Artificial Opening
      • 3E0J70 Antineoplastic
        • 3E0J704 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
        • 3E0J705 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
        • 3E0J70M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J72 Anti-infective
        • 3E0J728 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
        • 3E0J729 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J73 Anti-inflammatory
        • 3E0J73Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J76 Nutritional Substance
        • 3E0J76Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J77 Electrolytic and Water Balance Substance
        • 3E0J77Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7B Anesthetic Agent
        • 3E0J7BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7G Other Therapeutic Substance
        • 3E0J7GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7H Radioactive Substance
        • 3E0J7HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7K Other Diagnostic Substance
        • 3E0J7KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7N Analgesics, Hypnotics, Sedatives
        • 3E0J7NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7S Gas
        • 3E0J7SF Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7T Destructive Agent
        • 3E0J7TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
      • 3E0J7U Pancreatic Islet Cells
        • 3E0J7U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
        • 3E0J7U1 Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
    • 3E0J8 Via Natural or Artificial Opening Endoscopic
      • 3E0J80 Antineoplastic
        • 3E0J804 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0J805 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0J80M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J82 Anti-infective
        • 3E0J828 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0J829 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J83 Anti-inflammatory
        • 3E0J83Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J86 Nutritional Substance
        • 3E0J86Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J87 Electrolytic and Water Balance Substance
        • 3E0J87Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8B Anesthetic Agent
        • 3E0J8BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8G Other Therapeutic Substance
        • 3E0J8GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8H Radioactive Substance
        • 3E0J8HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8K Other Diagnostic Substance
        • 3E0J8KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8N Analgesics, Hypnotics, Sedatives
        • 3E0J8NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8S Gas
        • 3E0J8SF Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8T Destructive Agent
        • 3E0J8TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0J8U Pancreatic Islet Cells
        • 3E0J8U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0J8U1 Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic